Literature DB >> 3099437

Trypanosoma cruzi: zymodemes associated with acute and chronic Chagas' disease in central Brazil.

A O Luquetti, M A Miles, A Rassi, J M de Rezende, A A de Souza, M M Póvoa, I Rodrigues.   

Abstract

The clinical characteristics of acute and chronic Chagas' disease in central Brazil are described (29 acute cases and 111 chronic cases). The geographical distribution of Trypanosoma cruzi zymodemes in this region was mapped. Zymodeme (Z) 1 was identified in 12 acute cases, Z2 in 13 and repeated xenodiagnosis gave the same zymodeme identification. The clinical pictures of the Z1 and Z2 acute phases were similar. Resistance to benznidazole treatment occurred after either Z1 or Z2 acute infections. Only 14 positive xenodiagnosis were obtained from the 111 chronic phase patients examined. For 12 of these 14 patients the zymodeme was identified. All 12 carried Z2, 10 of whom had mega involvement. There were several possible explanations for the failure to detect T. cruzi Z1 in chronic Chagas' disease with mega syndromes: suggestions were made for follow-up investigations.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3099437     DOI: 10.1016/0035-9203(86)90347-0

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  24 in total

1.  Variability of kinetoplast DNA gene signatures of Trypanosoma cruzi II strains from patients with different clinical forms of Chagas' disease in Brazil.

Authors:  Eliane Lages-Silva; Luis Eduardo Ramírez; André Luiz Pedrosa; Eduardo Crema; Lúcia Maria da Cunha Galvão; Sérgio Danilo Junho Pena; Andrea Mara Macedo; Egler Chiari
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

2.  Chagas disease: increased parasitemia during pregnancy detected by hemoculture.

Authors:  Liliane da Rocha Siriano; Alejandro Ostermayer Luquetti; Juliana Boaventura Avelar; Neusa Leal Marra; Ana Maria de Castro
Journal:  Am J Trop Med Hyg       Date:  2011-04       Impact factor: 2.345

3.  Prevalence of antibodies to 72-kilodalton glycoprotein (GP72) in patients with Chagas' disease and further evidence of zymodeme-associated expression of GP72 carbohydrate epitopes.

Authors:  M Schechter; A F Stevens; A O Luquetti; D Snary; A K Allen; M A Miles
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

Review 4.  Chagas Disease in the United States: a Public Health Approach.

Authors:  Caryn Bern; Louisa A Messenger; Jeffrey D Whitman; James H Maguire
Journal:  Clin Microbiol Rev       Date:  2019-11-27       Impact factor: 26.132

5.  Cardiac morbidity due to Chagas' disease in a rural community in Bolivia.

Authors:  T Weinke; K Ueberreiter; M Alexander
Journal:  Epidemiol Infect       Date:  1988-12       Impact factor: 2.451

Review 6.  Trypanosoma cruzi antioxidant enzymes as virulence factors in Chagas disease.

Authors:  Lucía Piacenza; Gonzalo Peluffo; María Noel Alvarez; Alejandra Martínez; Rafael Radi
Journal:  Antioxid Redox Signal       Date:  2012-05-21       Impact factor: 8.401

Review 7.  Chagas Disease Diagnostic Applications: Present Knowledge and Future Steps.

Authors:  V Balouz; F Agüero; C A Buscaglia
Journal:  Adv Parasitol       Date:  2016-11-14       Impact factor: 3.870

8.  Trypanosoma cruzi: clones isolated from the Colombian strain, reproduce the parental strain characteristics, with ubiquitous histotropism.

Authors:  Edson Camandaroba; Torriceli S Thé; Daniel Huber Pessina; Sonia G Andrade
Journal:  Int J Exp Pathol       Date:  2006-06       Impact factor: 1.925

9.  Homogeneity of Trypanosoma cruzi I, II, and III populations and the overlap of wild and domestic transmission cycles by Triatoma brasiliensis in northeastern Brazil.

Authors:  Antonia Cláudia Jácome da Câmara; Eliane Lages-Silva; George Harisson Felinto Sampaio; Daniella Alchaar D'Ávila; Egler Chiari; Lúcia Maria da Cunha Galvão
Journal:  Parasitol Res       Date:  2013-01-31       Impact factor: 2.289

10.  Enzymes of the antioxidant network as novel determiners of Trypanosoma cruzi virulence.

Authors:  L Piacenza; M P Zago; G Peluffo; M N Alvarez; M A Basombrio; R Radi
Journal:  Int J Parasitol       Date:  2009-06-06       Impact factor: 3.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.